adr_usa_0353|ADAP|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0353|ADAP|Long Name|Adaptimmune Therapeutics PLC Total Current Assets (Quarterly) (USD)|Adaptimmune Therapeutics PLC Cash and Short Term Investments (Quarterly) (USD)|Adaptimmune Therapeutics PLC Inventories (Quarterly) (USD)|Adaptimmune Therapeutics PLC Net PP&E (Quarterly) (USD)|Adaptimmune Therapeutics PLC Goodwill and Intangibles (Quarterly) (USD)|Adaptimmune Therapeutics PLC Total Liabilities (Quarterly) (USD)|Adaptimmune Therapeutics PLC Total Current Liabilities (Quarterly) (USD)|Adaptimmune Therapeutics PLC Total Long Term Liabilities (Quarterly) (USD)|Adaptimmune Therapeutics PLC Total Deposits (Quarterly) (USD)|Adaptimmune Therapeutics PLC Book Value (Quarterly) (USD)|Adaptimmune Therapeutics PLC Retained Earnings (Quarterly) (USD)|Adaptimmune Therapeutics PLC Treasury Stock (Quarterly) (USD)|Adaptimmune Therapeutics PLC EV to Revenues|Adaptimmune Therapeutics PLC EV to Earnings|Adaptimmune Therapeutics PLC EV to Free Cash Flow|Adaptimmune Therapeutics PLC EV to Assets (Quarterly)|Adaptimmune Therapeutics PLC PS Ratio|Adaptimmune Therapeutics PLC PE Ratio|Adaptimmune Therapeutics PLC Price to Book Value|Adaptimmune Therapeutics PLC PEG Ratio|Adaptimmune Therapeutics PLC Debt to Equity Ratio|Adaptimmune Therapeutics PLC Dividend Yield|Adaptimmune Therapeutics PLC Shareholder Yield (TTM)|Adaptimmune Therapeutics PLC Percent of Shares Outstanding Short|Adaptimmune Therapeutics PLC Total Receivables (Quarterly) (USD)|Adaptimmune Therapeutics PLC Total Payables (Quarterly) (USD)|Adaptimmune Therapeutics PLC Total Capital Stock (Quarterly) (USD)|Adaptimmune Therapeutics PLC Return on Invested Capital|Adaptimmune Therapeutics PLC Quality Ratio Score|Adaptimmune Therapeutics PLC Momentum Score|Adaptimmune Therapeutics PLC Beta (1Y)|Adaptimmune Therapeutics PLC Sustainable Growth Rate (TTM)|Adaptimmune Therapeutics PLC Institutional Investor Ownership Percentage|Adaptimmune Therapeutics PLC Average Diluted Shares Outstanding (Quarterly)|Adaptimmune Therapeutics PLC Total Employees (Annual)|Adaptimmune Therapeutics PLC EPS Diluted (Quarterly) (USD)|Adaptimmune Therapeutics PLC Dividend Per Share (Quarterly) (USD)|Adaptimmune Therapeutics PLC Revenue (Quarterly) (USD)|Adaptimmune Therapeutics PLC Gross Profit (Quarterly) (USD)|Adaptimmune Therapeutics PLC SG&A Expense (Quarterly) (USD)|Adaptimmune Therapeutics PLC Pre-Tax Income (Quarterly) (USD)|Adaptimmune Therapeutics PLC Net Income (Quarterly) (USD)|Adaptimmune Therapeutics PLC Net Interest Income (Quarterly) (USD)|Adaptimmune Therapeutics PLC Price (USD)|Adaptimmune Therapeutics PLC Total Return Price (USD)|Adaptimmune Therapeutics PLC Enterprise Value (USD)|Adaptimmune Therapeutics PLC 30-Day Average Daily Volume|Adaptimmune Therapeutics PLC 1 Year Price Returns (Daily)||
adr_usa_0353|ADAP|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0353|ADAP|201406|54.0876|51.274||1.4307|0|53.1083|53.1083|0||2.41|-32.2632||||||||||||||1.8888|9.5071|0.31|||||||||||||||||||||||
adr_usa_0353|ADAP|201409||||||||||||||||||||||||||||||||||70.7853||-0.0461||1.5331||1.8319|-3.6103|-3.266|0.0682|||||||
adr_usa_0353|ADAP|201412|134.868|126.2405||2.8468||45.8505|45.8505|0||91.8612|-34.0836||||||||||0||||8.6275|45.8505|0.0062|||||||70.7853||-0.0225||2.2678||1.4164|-2.0366|-1.5917|0.131|||||||
adr_usa_0353|ADAP||||||||||||||||||||||||||||||||||||||||||||||||||16|16
adr_usa_0353|ADAP|201506|||||||||||||||||||14.1245|||0||1.6386|||||||||||116|||||||||18.33|18.33|1238.5032|306476.5333||17.45|17.45
adr_usa_0353|ADAP|201509|282.5562|271.9135||11.5747|0.1788|46.632|33.1767|13.4553||250.6781|-44.9393|||||1.9353|||9.0233||0|0||2.0896|10.5078|5.0054|0.644|||||||70.7853||-0.0182||3.9401||4.8751|-2.1064|-1.3593|0.2303|11.71|11.71|575.3865|145662.3667||8.92|8.92
adr_usa_0353|ADAP|201512|||||||||||||||||||3.205|||0||2.0333||||||||||||||||||||11.35|11.35|590.2515|329868.5667||12.29|12.29
adr_usa_0353|ADAP|201603|238.561|226.103||13.845|1.14|42.614|19.838|22.776||218.946|-105.489||32.7782|-16.0318|-7.6917|1.3358|53.9908||2.2562||0|0|-16.3776|1.6078|0.001|2.976|0.682|-11.6439||||-15.4589||70.7853||-0.24||2.918||5.267|-15.517|-15.576|0.259|7.99|7.99|275.9647|188859.5||8.85|8.85
adr_usa_0353|ADAP|201606|218.182|205.925||13.444|1.01|42.569|20.137|22.432||196.991|-127.584||39.2407|-9.1324|-7.4954|1.5486|61.0229||2.6252||0|0|0.7095|0.9449|0|3.019|0.682|-21.4229||3|1.461|-26.6939||70.7853||-0.3||0.328||6.172|-21.802|-22.095|0.291|8.12|8.12|358.5836|150289.4333|-55.4461|8.91|8.91
adr_usa_0353|ADAP|201609|199.544|187.504||15.086|1.127|42.64|22.661|19.979||180.004|-146.078||32.0527|-5.4157|-6.1224|1.3992|53.8349||2.5872||0|0|0|0.5063||3.765|0.682|-30.6475||2|1.3222|-30.6476||70.7853||-0.24||2.416||5.424|-18.39|-18.494|0.289|7.2|7.2|310.8077|103165.8667|-41.1028|6.92|6.92
adr_usa_0353|ADAP|201612|198.751|181.473|1.192|27.899|1.268|68.373|40.27|28.103||166.142|-161.492||10.3287|-1.4704|-1.5611|0.4488|29.8562||1.6359||0|0|0|0.6209|7.727|13.364|0.683|-35.3385||2|4.4424|-35.3385||70.7867|298|-0.24||8.536||6.345|-14.978|-15.414|0.271|4.16|4.16|98.4686|128116.1667|-66.7488|4.12|4.12
adr_usa_0353|ADAP|201703|222.932|203.673||35.092|1.31|57.654|31.912|25.742||208.326|-183.274||19.3054|-3.5087|-3.3846|1.0261|27.6583||2.3896|-0.0221|0|0|-12.8825|0.3417|0.107|7.944|0.801|-40.0785||1|2.0007|-40.0785||71.4936||-0.3||2.857||6.463|-21.551|-21.782|0.24|4.59|4.59|244.9528|268815.6667|-32.2263|6.07|6.07
adr_usa_0353|ADAP|201706|237.744|220.021||38.922|1.431|54.784|30.253|24.531||229.495|-203.489||16.6154|-2.6332|-2.913|0.7031|23.5421||2.1052|-0.0188|0|0|-24.5699|0.3707|1.406|4.577|0.853|-38.6892||2|2.2892|-38.6892||92.7961||-0.24||3.521||7.71|-20.05|-20.215|0.506|4.69|4.69|243.3077|227154.7|-41.5212|4.53|4.53
adr_usa_0353|ADAP|201709|253.904|231.858||39.771|1.374|72.392|68.572|3.82||228.985|-204.367||30.5829|-9.1859|-5.8947|1.7766|35.3868||3.2681|-0.1039|0|0|-13.4456|0.7129|4.063|8.556|0.854|-28.7718||3|1.7659|-28.7718||93.54|335|-0.0094||27.185||8.111|-0.653|-0.878|0.705|8.02|8.02|530.0022|465794.5667|11.3889|8.74|8.74
adr_usa_0353|ADAP|201712|230.183|208.261|3.76|40.679|1.337|78.163|74.314|3.849||202.984|-231.63||9.6252|-5.9535|-6.6879|1.4852|13.2699||2.7821||0|0|-16.4849|1.6672|11.66|14.119|0.854|-33.8526||9|-4.872|-33.8526||93.582|371|-0.3||4.27||8.822|-27.433|-27.263|0.765|6.8|6.8|405.2109|255922|63.4615|7.57|7.57
adr_usa_0353|ADAP|201803|195.663|161.834|3.843|41.235|1.238|55.806|51.922|3.884||191.262|-244.063||20.4234|-12.8956|-9.7404|3.6241|24.3126||4.8326||0|0|-3.9509|1.3102|21.188|5.509|0.858|-32.7194|||0.525|-32.7194||93.7303|390|-0.24||8.196||11.204|-20.951|-21.078|0.659|10.47|10.47|772.6775|780000.5333|128.1046|11.23|11.23
adr_usa_0353|ADAP|201806|161.654|129.028|2.993|39.472|1.196|46.197|42.31|3.887||165.102|-287.568||22.8336|-10.656|-11.2544|4.6933|26.3757||6.0002||0|0|0|2.3289|18.605|4.131|0.86|-45.717||10|0.3645|-45.717||94.1995||-0.48||9.038||11.291|-43.743|-43.845|0.54|12.19|12.19|985.7728|416688.2667|159.9147|11.58|11.58
adr_usa_0353|ADAP|201809|261.605|237.733|1.19|38.137|1.515|33.47|29.566|3.904||276.155|-282.326||25.6664|-13.5695|-12.8546|3.8104|25.4199||8.3506|-14.3153|0|0|-7.0301|2.3087|13.849|7.295|0.939|-40.8384||9|-0.1911|-40.8384||103.6274||0.06||40.792||10.29|5.375|5.242|0.606|13.2|13.2|1249.6698|439050.9333|64.5885|14.16|14.16
adr_usa_0353|ADAP|201812|231.095|205.134|1.087|36.118|1.473|29.851|24.437|5.414||246.885|-318.499||4.8286|-4.1331|-2.9936|1.4316|7.9598||1.9501|-0.2482|0|0|-16.5726|3.0105|18.156|4.083|0.939|-44.2789||3|2.5018|-44.2789||102.6612|430|-0.36||1.479||10.816|-36.038|-36.173|1.044|5.15|5.15|300.8046|706119.1333|-24.0413|5.72|5.72
adr_usa_0353|ADAP|201903|200.301|168.158|0.862|60.165|1.529|50.785|23.435|27.35||219.655|-345.911||4.1195|-2.7608|-2.2469|1.0432|7.1218||1.8238|-0.2099|0|0|-22.1314|4.0952|22.488|5.391|0.94|-46.4889||2|1.449|-46.4889||104.6575||-0.24||||11.773|-27.41|-27.412|0.952|4.3|4.3|245.1285|277768.1667|-61.7097|5.09|5.09
adr_usa_0353|ADAP|201906|175.133|133.406|1.755|55.229|2.066|52.53|28.293|24.237||186.991|-386.998|||-2.908|-2.5578|1.2072|||1.8976|-0.1336|0|0|-23.5837|3.4918|30.773|4.344|0.943|-45.4106||1|2.0607|-45.4106||104.8927||-0.42||0.157||10.148|-41.022|-41.087|0.757|3.98|3.98|248.6523|263766.4667|-69.1234|3.81|3.81
adr_usa_0353|ADAP|201909|146.97|102.86|1.522|52.204|2.274|60.568|37.401|23.167||147.683|-426.3|||-0.3885|-0.3523|0.2686|||0.8939||0|0|0|3.4467|31.726|5.535|0.943|-66.8174||1|2.2727|-66.8174|73.1298|105.1445||-0.36||0.237||10.741|-39.215|-39.302|0.615|1.59|1.59|33.7461|259606.1667|-86.6274|1.43|1.43
adr_usa_0353|ADAP|201912|120.489|89.542|1.459|51.857|2.198|57.905|34.341|23.564||123.638|-455.664|||-0.2673|-0.3146|0.2019|||0.9827|-0.0229|0|0|0|1.4539|20.671|6.357|0.943|-74.1551||1|3.4047|-74.1551|69.5414|105.1685|400|-0.3||0.728||10.729|-29.276|-29.364|0.448|1.38|1.38|42.2685|511709.5333|-79.1304|1.2|1.2
adr_usa_0353|ADAP|202003|227.761|196.429|0.952|48.172|2.366|99.204|29.816|69.388||186.037|-483.831||83.5922|-1.1413|-2.4327|0.5518|158.3529||2.9984|-0.0734|0|0|-25.5912|0.5448|23.004|7.066|1.139|-79.8144||4|2.297|-79.8144|96.9177|123.2922||-0.24||0.761||9.261|-28.097|-28.167|0.73|2.85|2.85|281.1726|450142.8333|-36.7442|2.63|2.63
adr_usa_0353|ADAP|202006|458.087|418.988|1.521|45.912|2.134|104.616|38.559|66.057||407.585|-513.711||655.5337|-8.9073|-19.9879|2.2036|528.7218||3.7971|-0.4683|0|0|-21.606|2.4043|26.746|8.766|1.324|-60.2286||10|3.4922|-60.2286|91.0838|137.1209||-0.24||0.502||10.295|-29.855|-29.88|1.147|10.01|10.01|1234.37|5900973.5|149.005|9.68|9.68
adr_usa_0353|ADAP|202009|||||||||||||349.7536||-14.9824||404.5963||2.9057|-0.3584||0||3.4421||||||10|2.2291||91.3665|||||||||||7.66|7.66|779.2511|673028.3|421.0884|8.3|8.3